These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 15353487

  • 1. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
    Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS.
    Circulation; 2004 Sep 14; 110(11):1492-8. PubMed ID: 15353487
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.
    Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF.
    Nat Med; 2001 Jun 14; 7(6):699-705. PubMed ID: 11385507
    [Abstract] [Full Text] [Related]

  • 5. Role of the fatty acid binding protein mal1 in obesity and insulin resistance.
    Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, Parker RA, Brüning J, Hertzel AV, Bernlohr DA, Hotamisligil GS.
    Diabetes; 2003 Feb 14; 52(2):300-7. PubMed ID: 12540600
    [Abstract] [Full Text] [Related]

  • 6. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice.
    Cao H, Maeda K, Gorgun CZ, Kim HJ, Park SY, Shulman GI, Kim JK, Hotamisligil GS.
    Diabetes; 2006 Jul 14; 55(7):1915-22. PubMed ID: 16804058
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M.
    Atherosclerosis; 2014 Jan 14; 232(1):40-51. PubMed ID: 24401215
    [Abstract] [Full Text] [Related]

  • 11. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.
    Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, Cao Q, Atsumi G, Malone H, Krishnan B, Minokoshi Y, Kahn BB, Parker RA, Hotamisligil GS.
    Cell Metab; 2005 Feb 14; 1(2):107-19. PubMed ID: 16054052
    [Abstract] [Full Text] [Related]

  • 12. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice.
    Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, Storch J, Feinberg MW, Hsieh CM, Haber E, Lee ME.
    FASEB J; 2001 Aug 14; 15(10):1774-6. PubMed ID: 11481226
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 14; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 15. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, Véniant MM.
    Am J Physiol Endocrinol Metab; 2008 Mar 14; 294(3):E496-505. PubMed ID: 18160459
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes.
    Lyngdorf LG, Gregersen S, Daugherty A, Falk E.
    Cardiovasc Res; 2003 Oct 01; 59(4):854-62. PubMed ID: 14553825
    [Abstract] [Full Text] [Related]

  • 19. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.
    Yang H, Roberts LJ, Shi MJ, Zhou LC, Ballard BR, Richardson A, Guo ZM.
    Circ Res; 2004 Nov 26; 95(11):1075-81. PubMed ID: 15528470
    [Abstract] [Full Text] [Related]

  • 20. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.
    Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM.
    Science; 1996 Nov 22; 274(5291):1377-9. PubMed ID: 8910278
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.